High CD40 expression was detected in the cytoplasm of hormone-receptor–positive breast cancer, whereas it was detected on the surface membrane of triple-negative breast cancer (Kim et al., 2015; Slobodova et al., 2011). This evidence concerns the gene NR4A1 and triple-negative breast carcinoma.